ATLN
Atlantic International Corp.NASDAQHealthcare$3.51+0.00%ClosedMarket Cap: $278.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-8.26
P/S
0.59
EV/EBITDA
-5.41
DCF Value
$-59.45
FCF Yield
1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
10.9%
Operating Margin
-7.3%
Net Margin
-22.7%
ROE
606.4%
ROA
-91.5%
ROIC
-59.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $110.1M | 11.3% | $-8.7M | $-10.8M | $-0.20 | — |
| Q2 2025 | $102.9M | 11.1% | $-8.7M | $-10.7M | $-0.20 | — |
| Q1 2025 | $102.8M | 10.9% | $-9.4M | $-10.7M | $-0.20 | — |
| Q4 2024 | $129.5M | 10.3% | $-5.9M | $-68.7M | $-1.29 | — |
| FY 2024 | $442.6M | 10.7% | $-21.8M | $-135.5M | $-3.68 | — |
| Q3 2024 | $107.8M | 11.0% | $-6.5M | $-7.0M | $-0.16 | — |
| Q2 2024 | $104.6M | 11.0% | $-8.3M | $-54.9M | $-1.96 | — |
| Q1 2024 | $100.6M | 10.4% | $-1.1M | $-4.9M | $-0.04 | — |
| Q4 2023 | $116.2M | 10.8% | $-2.4M | $-5.4M | $-0.05 | — |
| FY 2023 | $401.4M | 11.7% | $-3.5M | $-15.3M | $-0.60 | — |
| Q3 2023 | $97.8M | 11.9% | $-380.7K | $-3.9M | $-0.05 | — |
| Q2 2023 | $89.4M | 12.2% | $-1.1M | $-3.6M | $-0.06 | — |